Parathyroid hormone 1-34(teriparatide) treatment in pelvic insufficiency fractures - a report of two cases -

J Bone Metab. 2012 Nov;19(2):147-51. doi: 10.11005/jbm.2012.19.2.147. Epub 2012 Nov 16.

Abstract

As a result of aging population, the incidence of pelvic insufficiency fracture has been increasing. Pain-related immobility caused by pelvic insufficiency fractures may result in a serious dependency and high mortality with preexisting comorbidities. We present two cases of pelvic insufficiency fracture in elderly patients which had good clinical outcome by parathyroid hormone 1-34(teriparatide) treatment as well as a literature review.

Keywords: Osteoporosis; Parathyroid hormone; Pelvis; Pelvis (Pelvic) insufficiency fracture.

Publication types

  • Case Reports